VION Ingredients to acquire BAIC Protein’s activities

Production starts in Australia

With the acquisition of BAIC Protein’s activities in Maryborough, VION Ingredients has today commenced the production of blood plasma and haemoglobin in Australia. The production of blood plasma and haemoglobin is in line with VION Ingredients’ strategy to occupy international positions on the worldwide market for blood products. This acquisition will provide VION Ingredients with improved access to the rapidly developing Asian market. BAIC Protein will become part of the VION Ingredients company Sonac. This will also enable Sonac to provide services globally to its international clients.

Sonac processes animal by-products from the meat industry into useful, high-quality ingredients such as fats, proteins and minerals for application in a variety of sectors. Sonac is the number two on the world market for blood products.

BAIC Protein
BAIC Protein produces blood plasma and haemoglobin. The company employs 20 staff and is based in Maryborough, Australia. BAIC Protein’s name will be changed to Sonac Australia.

VION N.V. is an internationally operating food company with two core activities Food and Ingredients. The company creates high-quality foodstuffs for humans and animals. VION achieves an annual turnover of €8.9 billion and has well over 26,500 employees. VION is a non-listed company and has a single, agricultural shareholder the Zuidelijke Land- en Tuinbouworganisatie (ZLTO) [Dutch Southern Farmers and Market Gardeners Union] which has approximately 18,000 members. VION’s head office is located in Eindhoven (NL).
Note for the editors
For further information:

Marc van der Lee, Director Corporate Communications VION N.V.
Tel.: +31 889953731 or E-mail: